United Guardian (UG) Interest & Investment Income (2010 - 2026)
United Guardian's (UG) quarterly Interest & Investment Income came in at $70445.0 in Q2 2026, little changed year-over-year from $70573.0 in Q2 2025, and up 0.9% quarter-over-quarter from $69814.0 in Q1 2026.
Powered by 
Analysis
United Guardian (UG) Interest & Investment Income (2010 - 2026) Analysis & Trends
United Guardian has disclosed Interest & Investment Income across 17 years of filings, most recently posting $70445.0 for Q2 2026.
- In Q2 2026, Interest & Investment Income changed 0.18% year-over-year to $70445.0; the TTM figure through Jun 2026 stood at $350307.0 (down 10.6% YoY), while the FY2025 annual figure was $365308.0, down 15.96% from the prior year.
- Interest & Investment Income came in at $70445.0 for Q2 2026 at United Guardian, up from $69814.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $136665.0 in Q4 2024 to a low of $40550.0 in Q1 2022.
- Average Interest & Investment Income over 5 years is $82421.8, with a median of $77423.5 recorded in 2023.
- Year-over-year, Interest & Investment Income jumped 105.9% in 2024 and dropped 29.43% in 2025.
- Over 5 years, Interest & Investment Income stood at $90290.0 in 2022, then surged by 37.76% to $124387.0 in 2023, then advanced by 9.87% to $136665.0 in 2024, then retreated by 1.3% to $134883.0 in 2025, then sank by 47.77% to $70445.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $70445.0 in Q2 2026, $69814.0 in Q1 2026, and $134883.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.22 Bn | 626.46 Bn | 17.26 Bn | 219.00 Mn |
| 2 | AbbVie | 440.28 Bn | 433.71 Bn | 12.70 Bn | -679.00 Mn |
| 3 | Merck | 364.30 Bn | 357.16 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 268.44 Bn | 260.75 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.60 Bn | 146.90 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.56 Bn | 45.18 Bn | 10.79 Bn | 89.50 Mn |
| 7 | Revolution Medicines | 44.31 Bn | 44.31 Bn | - | 35.58 Mn |
| 8 | Incyte | 24.98 Bn | 20.45 Bn | 1.57 Bn | 38.12 Mn |
| 9 | United Therapeutics | 21.16 Bn | 18.49 Bn | 683.80 Mn | 31.50 Mn |
| 10 | United Guardian | 32.71 Mn | 23.12 Mn | 1.55 Mn | 70,445.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 70,445.00 |
| Mar 31, 2026 | 69,814.00 |
| Dec 31, 2025 | 134,883.00 |
| Sep 30, 2025 | 75,165.00 |
| Jun 30, 2025 | 70,573.00 |
| Mar 31, 2025 | 84,687.00 |
| Dec 31, 2024 | 136,665.00 |
| Sep 30, 2024 | 99,934.00 |
| Jun 30, 2024 | 100,007.00 |
| Mar 31, 2024 | 98,073.00 |
| Dec 31, 2023 | 124,387.00 |
| Sep 30, 2023 | 79,682.00 |
| Jun 30, 2023 | 54,950.00 |
| Mar 31, 2023 | 47,632.00 |
| Dec 31, 2022 | 90,290.00 |
| Sep 30, 2022 | 46,995.00 |
| Jun 30, 2022 | 58,860.00 |
| Mar 31, 2022 | 40,550.00 |
| Dec 31, 2021 | 109,710.00 |
| Sep 30, 2021 | 38,747.00 |